Source: Annual Congress 2007 - Tuberculosis control in the penitentiary and civilian sector
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
A. Isakov, Y. Andreev, A. Pushkaryev, Y. Karpeichik, A. Salnikov, A. Golubkov (Tomsk, Russian Federation; Boston, MA, United States Of America). MDR-TB treatment in prison setting. Eur Respir J 2007; 30: Suppl. 51, 2499

Member's Comments

No comment yet.

Related content which might interest you: MDR TB treatment in prison Source: Eur Respir J 2002; 20: Suppl. 38, 614s Year: 2002 Outcomes of MDR-TB treatment in penitentiary medical setting Source: Annual Congress 2008 - Tuberculosis in immigrants, disadvantaged populations, elderly, HIV-seropositives and in other risk groups Year: 2008 Psychiatric disorders in MDR TB patients on the treatment regimens under DOTS-plus programme in Tomsk oblast penitentiary system Source: Eur Respir J 2001; 18: Suppl. 33, 513s Year: 2001 DOTS-Plus treatment of MDR-TB patients with psychiatric disorders Source: Annual Congress 2007 - New methods to diagnose tuberculosis infection and disease and problems in tuberculosis care Year: 2007 Early outcomes in MDR-TB and XDR-TB patients treated with delamanid under compassionate use Source: Eur Respir J, 50 (1) 1700311; 10.1183/13993003.00311-2017 Year: 2017 Is prevalence of MDR TB and XDR TB decreasing in a tertiary care hospital in India? Source: International Congress 2017 – MDRTB: detection and management Year: 2017 MDR-TB and XDR-TB: drug resistance and treatment outcomes Source: Eur Respir J 2009; 34: 778 Year: 2009 Sputum culture conversion among the first cohorts of MDR-TB patients managed in Nigeria at a tertiary care hospital Source: International Congress 2014 – Mycobacterium tuberculosis infection and disease: clinical epidemiology 1 Year: 2014 Out-patient MDR-TB care in Moldova Source: International Congress 2015 – Management of TB: a patient focus Year: 2015 Prevalence of MDR TB and XDR TB in a tertiary care hospital in India Source: Annual Congress 2008 - Clinical epidemiology of tuberculosis Year: 2008 MDR-TB treatment outcomes in HIV positive patients Source: International Congress 2014 – Tuberculosis: from diagnosis to therapy and prevention Year: 2014 Impact of pre-treatment duration by first line drugs on treatment outcomes of patients with MDR-TB Source: International Congress 2015 – TB treatment: new drugs and drug resistance Year: 2015 Aspects of effective MDR-TB treatment in the prison hospital, Tomsk (Russia) Source: Eur Respir J 2006; 28: Suppl. 50, 17s Year: 2006 Impact of XDR-TB on treatment outcome of MDR-TB patients with standardized regimens Source: Annual Congress 2008 - The challenge of multidrug-resistant tuberculosis Year: 2008 First-line anti-TB drug resistance pattern and its trend in the national TB referral center in Iran Source: Annual Congress 2008 - Clinical epidemiology of tuberculosis III Year: 2008 A comparison of drug sensitivity pattern in category-I failure versus category-I relapse pulmonary TB patients attending a tertiary care hospital in South Punjab, Pakistan. Is WHO category-II ATT regimen appropriate? Source: Annual Congress 2013 –Drug-resistant tuberculosis Year: 2013 A review of the management of MDR-TB in a resource-limited setting in India Source: Annual Congress 2010 - Global tuberculosis control Year: 2010 Poor treatment outcomes of XDR-TB patients in resource-limited settings Source: Annual Congress 2012 - MDR- and XDR-TB: clinical and public health experiences Year: 2012 Linezolid in the treatment of patients with MDR TB and XDR TB Source: Annual Congress 2013 –Drug-resistant tuberculosis Year: 2013 Improving treatment adherence in TB patients using rehabilitation activities for co-morbid addiction conditions within Tomsk penitentiary system Source: Annual Congress 2007 - Tuberculosis control in the penitentiary and civilian sector Year: 2007